PTK2B and Alzheimer disease: Functionally, 41% of DE TEs localized to promoters or enhancers, and many overlapped snATAC-seq accessible regions near AD-risk genes (e.g., DOC2A, ABCA7, PTK2B, ABCB9), consistent with open chromatin marking regulatory activity (Pott and Lieb, 2015).